The economics of pharmaceutical innovation remains thinnly understood in the research community. This study discusses the theme of pharmaceutical innovation in terms of government's R&D investment, academic-industrual collaboration, and insurance benefits and pricing.
목차
Abstract 1 Chapter 1. Korean Pharmaceutical Industry and its policy 7 Session 1. Introduction 9 Session 2. Korea’s pharmaceutical industry today 12 Session 3. Direct investment in pharmaceutical R&D by the Koreangovernment 16 Session 4. Academic-industrial collaboration 20 Session 5. Insurance benefits and pricing 23 Session 6. Conclusion 26 Chapter 2. R&D Policy and Pharmaceutical Innovation 29 Session 1. Introduction 31 Session 2. Push and pull policies 33 Session 3. Government funding of R&D in pharmaceuticals 46 Session 4. Conclusion 59 Chapter 3. The Lessons for Korea Arising from the General Regulation on Innovative Health Products 63 Session 1. Background 65 Session 2. DRG pricing 71 Session 3. Value based pricing 76 Session 4. Regulatory Impacts on R&D 93 Session 5. Potential Regulatory Solutions to Lengthening Time toMarket 101 Session 6. Conclusions 105 Reference 109
